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Blood ﬂow rate (BFR) <300mL/min commonly is used to deﬁne hemodialysis catheter dysfunction and the need for interventions
to prevent complications. The objective of this study was to describe patterns of unplanned BFR <300mL/min during catheter
hemodialysis using data from DaVita dialysis facilities and the United States Renal Data System. Patients were included if they
received at least eight weeks of hemodialysis exclusively through a catheter between 08/04 and 12/06, and catheter hemodialysis
was the ﬁrst treatment modality following diagnosis of end-stage renal disease (ﬁrst access), or it immediately followed at least one
30-day period of dialysis exclusively through a ﬁstula or graft (replacement access). Actual BFR <300mL/min despite a planned
BFR ≥300mL/min deﬁned catheter dysfunction during each dialysis session. There were 3,364 patients, 268,363 catheter dialysis
sessions, and 19,118 (7.1%) sessions with catheter dysfunction. Almost two-thirds of patients had ≥1 catheter dysfunction session,
and 30% had ≥1 catheter dysfunction session per month. Patients with catheter as a replacement access had a higher rate of
catheter dysfunction than those with a catheter as ﬁrst access (hazard ratio: 1.13; P = 0.04). Catheter dysfunction aﬀects almost
one-third of catheter dialysis patients each month and two-thirds overall.
1.Introduction
Hemodialysis catheter dysfunction often is deﬁned as blood
ﬂow rate (BFR) <300mL/min [1], including in the National
Kidney Foundation’s Kidney Disease Outcome Quality Ini-
tiative (NKF-KDOQI) clinical practice guidelines [2]. Other
deﬁnitions of catheter dysfunction reported in the literature
include frequent arterial and venous pressure alarms, poor
conductance, and poor dialysis eﬃciency based on urea
reduction ratio or Kt/V calculations [3–8]. Among these
deﬁnitions, the one recommended by NKF-KDOQI may
be of particular signiﬁcance to providers and payers. This
is especially true in the United States, where NKF-KDOQI
guidelines play a prominent role in shaping clinical practice,
including through the Centers for Medicare and Medicaid
Services’ (CMS) End-Stage Renal Disease (ESRD) Clinical
Performance Measures Project [9]. Since the recommenda-
tion to deﬁne catheter dysfunction as BFR <300mL/min
was opinion based, concerns have been raised that it
has been interpreted to mean BFR must be kept above
300mL/min to maintain adequate dialysis. However, one
recent study showed that mean blood ﬂows <300mL/min
were not commonly associated with dialysis inadequacy [1],
prompting the authors to conclude that this deﬁnition of
catheter dysfunction could result in a signiﬁcant number of
unnecessary interventions.
Presently, there is very little information on the epi-
demiology of hemodialysis catheter dysfunction deﬁned as2 International Journal of Nephrology
BFR <300mL/min. One exception is a study by Moist and
colleagues on the association between BFR and dialysis
adequacy, which found that mean blood ﬂow <300mL/min
occurred in 10% of patients [1]. However, this was a
cross-sectional study of only 259 patients conducted at
two university-based tertiary hemodialysis care programs.
Data on BFR are not present in the United States Renal
Data System (USRDS), and they are not collected as part
of the CMS ESRD Clinical Performance Measures Project.
Without ﬁrst understanding the epidemiology of catheter
dysfunction deﬁned according to NKF-KDOQI guidelines, it
is diﬃcult to assess the potential impact of this guideline on
clinical outcomes and on interventions, both necessary and
unnecessary.
The objective of this study was to describe patterns of
hemodialysis catheter dysfunction, deﬁned as unplanned
BFR <300mL/min, in a large cohort of ESRD patients.
2. Methods
2.1. Study Design and Setting. An observational cohort
study was performed using clinical and administrative data
from DaVita Inc., merged with administrative and Medicare
claims data from the USRDS. DaVita owns and operates
more than 1,400 outpatient dialysis facilities in the United
States and has acute units in more than 700 hospitals. Facil-
ities are located in 43 states and the District of Columbia.
Nationwide, DaVita serves approximately 110,000 patients.
The DaVita clinical data warehouse is a repository for
detailed demographic, treatment, medication, and labora-
tory information. Information is available for each patient’s
individual dialysis sessions, allowing the investigator to
reconstruct detailed longitudinal treatment histories.
The USRDS is a national data system that collects, ana-
lyzes, and distributes information about ESRD in the United
States [10]. It contains demographic, diagnosis, and treat-
ment history information for all Medicare beneﬁciaries with
ESRD, a point-prevalent cohort of approximately 570,000 in
the second quarter of 2009 [11]. Also, it contains 100% of
Medicare inpatient and outpatient bills for these patients.
Presently, Medicare Part D oral medication claims are not
included.
Thedatasetusedinthisprojectwascomposedofapoint-
prevalent dialysis patient population in August 2004, with a
maximum follow-up period through December 31, 2006.
2.2.Participants. Patientsmeetingthefollowingcriteriawere
included in this study: they received at least eight continuous
weeksofhemodialysisexclusivelythroughacatheterbetween
August 1, 2004, and December 31, 2006; either catheter
hemodialysis was their ﬁrst treatment modality following
diagnosis of ESRD (catheter as ﬁrst access), or catheter
hemodialysis immediately followed at least one month dur-
ing which the patient was dialyzed exclusively through
an arteriovenous ﬁstula or graft (catheter as replacement
access); in the ﬁrst eight weeks of catheter dialysis, they did
not have a gap between two consecutive outpatient dialysis
sessions >30 days during which time they were not hospi-
talized; they had both Part A and Part B Medicare coverage
during the entire catheter dialysis period; they did not have a
kidney transplant during the entire catheter dialysis period;
at least 95% of their catheter dialysis sessions had actual
and planned blood ﬂow rates between 100mL/min and
500mL/min; they were alive and in the data set for at least
90 days following the ﬁrst catheter dialysis session. Planned
and actual BFR values <100mL/min or >500mL/min were
set to missing to minimize the potential impact of coding
errors. In the ﬁnal cohort, 99.9% of BFR values were within
this range. The observation period was deﬁned as beginning
at the ﬁrst catheter dialysis session and ending at the last
catheter dialysis session that was uninterrupted by either a
change in access or dialysis modality.
2.3. Variables. Using DaVita data, we reconstructed a longi-
tudinalhistoryofcatheterdialysistreatmentsforeachpatient
during their observation period. Reasons for reaching the
end of the observation period were deﬁned as (a) death, if
the patient died on or before December 31, 2006, and if the
last catheter dialysis session was within 30 days of death, (b)
end of data (censored), if the last catheter dialysis session was
within 30 days of December 31, 2006, or (c) change in access
type or modality, if the last observed catheter dialysis session
was not due to either death or the end of the data.
The primary outcome variable was catheter dysfunction,
which was deﬁned as actual BFR <300mL/min despite
a planned BFR ≥300mL/min. Actual BFR was measured
approximately one hour after the beginning of the dialysis
session. We elected to make our deﬁnition of catheter dys-
function more restrictive than in the NKF/KDOQI clinical
practice guidelines for vascular access to eliminate misclassi-
ﬁcationofcatheterdysfunctionwheretheintent,asindicated
by planned BFR, was to provide BFR <300mL/min.
Medicalresourceandcostoutcomevariablesinthisstudy
were total direct medical costs to Medicare, missed dialysis
sessions due to access problems, access-related procedures,
and all-cause hospitalization. The DaVita data contained a
record for each missed session. Each record had the date of
the missed session and the reason for the missed session,
including “access problems.” Access-related procedures were
identiﬁed using the Medicare claims data, based on the
following Health Care Common Procedure Coding System
(HCPCS) codes: injection for catheter evaluation with
ﬂuoroscopy (36598); thrombolytic declotting of catheter
(36593); mechanical removal of clot (36596); mechanical
removal of intraluminal (intracatheter) obstructive material
(75902); injection of “TPA” (J2997); tunneled catheter
exchange or replacement (36581); the combination of
removal of tunneled catheter (36589) plus tunneled catheter
insertion (36558). Hospitalizations consisted of all acute care
admissions for any reason and were identiﬁed from the
Medicare claims.
2.4. Analyses. Patients were described according to their
demographic and clinical characteristics at the time they
began catheter dialysis, including age, gender, race, under-
lying cause of renal failure, dialysis vintage, ESRD network,
Charlson Comorbidity Index [12], and whether catheter was
their ﬁrst dialysis access or a replacement for a graft orInternational Journal of Nephrology 3
Table 1: Patient characteristics.
Type of catheter use
All First access Replacement access
P value N = 3,364 n = 718 n = 2,646
Count % Count % Count %
Age
18–49 712 21.2 150 20.9 562 21.2
<0.001 50–64 1,112 33.1 209 29.1 903 34.1
65–74 813 24.2 165 23 648 24.5
≥75 727 21.6 194 27 533 20.1
Gender
Male 1,728 51.4 366 51 1,362 51.5 0.81
Female 1,636 48.6 352 49 1,284 48.5
Race
White 1,694 50.4 455 63.4 1,239 46.8
<0.0001 Black 1,417 42.1 222 30.9 1,195 45.2
Other 253 7.5 41 5.7 212 8
Underlying cause of renal failure
Diabetes 1,533 45.6 329 45.8 1,204 45.5
0.09 Hypertension 957 28.4 200 27.9 757 28.6
Glomerulonephritis 341 10.1 59 8.2 282 10.7
Other 533 15.8 130 18.1 403 15.2
Charlson Comorbidity Index
0 1,239 36.8 332 46.2 907 34.3
<0.0001 1-2 716 21.3 160 22.3 556 21
3-4 779 23.2 128 17.8 651 24.6
≥5 630 18.7 98 13.6 532 20.1
Dialysis network
01 New England/02 (NY) 121 3.6 24 3.3 97 3.7
<0.001
03 (NJ)/04 (PA) 128 3.8 30 4.2 98 3.7
05 (VA) 350 10.4 75 10.4 275 10.4
06 (NC)/08 (MS) 460 13.7 66 9.2 394 14.9
07 (FL) 242 7.2 63 8.8 179 6.8
09 (IN) 130 3.9 35 4.9 95 3.6
10 (IL) 101 3 24 3.3 77 2.9
11 (MN) 268 8 72 10 196 7.4
12 (MO) 115 3.4 38 5.3 77 2.9
13 (OK) 134 4 33 4.6 101 3.8
14 (TX) 416 12.4 76 10.6 340 12.8
15 (CO) 231 6.9 50 7 181 6.8
16 (WA)/17 (N-CA) 311 9.2 60 8.4 251 9.5
18 (S-CA) 357 10.6 72 10 285 10.8
ﬁstula. Multivariate analysis with Cox’s proportional hazards
model was used to examine adjusted associations between
patient factors and the risk of catheter dysfunction. For the
medical resource and cost analyses, patients with at least
one catheter dysfunction session were divided into quintiles
based on the number of catheter dysfunction sessions per
month on catheter dialysis. Medical resource use and costs
were compared, unadjusted, across the ﬁve groups. Analysis
ﬁle construction and all analyses were performed in SAS
(version 9.1.3) [13].
3. Results
There were 3,364 patients who met the inclusion and
exclusion criteria. The average age was 62 years, 51% were
male gender, 42% were black race, 46% had diabetes, and4 International Journal of Nephrology
Table 2: Catheter dysfunction∗.
All patients
N = 3,364
Catheter as
ﬁrst access
N = 718
Catheter as replacement access
All
N = 2,646
Graft
N = 1,758
Fistula
N = 888
Patient months 23,045 5,663 17,382 11,579 5,803
Catheter sessions 268,363 66,285 202,078 134,250 67,828
Patients with ≥1 CD session 2,132 454 1,678 1,123 555
% Patients with ≥1 CD session 63% 63% 63% 64% 63%
Median time (days) to 1st CD session 95 105 94 89 108
Total CD sessions 19,118 4,024 15,094 10,085 5,009
Rate of CD per patient month at risk 0.83 0.71 0.87 0.87 0.86
M e a n#C Ds e s s i o n sa m o n gp a t i e n t s
with ≥1 CD session 9.0 8.9 9.0 9.0 9.0
∗Catheter dysfunction was deﬁned as unplanned blood ﬂow rate during the dialysis session of <300mL/min.
CD: catheter dysfunction.
28% had hypertension reported as the underlying cause of
renalfailure(Table 1).Patientswithcatheterasareplacement
accesswereolder,hadbeendiagnosedwithESRDforalonger
period of time, and had higher Charlson Comorbidity Index
scores [12]. Those with catheter as ﬁrst access were more
likely to be white race. Within the catheter as replacement
group,patientswithcatheterreplacingagraftwereolder,had
higher Charlson Comorbidity Index scores, and were more
likely to be female gender and black race, compared to those
with catheter replacing a ﬁstula.
Overall, the median duration of catheter dialysis in
the cohort was 143 days, the ﬁrst 56 days of which were
mandated by the eligibility criteria. The median duration
of catheter dialysis was signiﬁcantly longer for those with
catheter as ﬁrst access compared to replacement access (159
days versus 138 days: P<0.0001 by Log Rank) (Figure 1).
Among those with catheter as a replacement access, there
wasnodiﬀerencebetweenthosewithpriorgraft(median139
days)andthosewithpriorﬁstula(median136days:P = 0.84
by Log Rank).
The cohort accounted for more than 23,000 patient-
months of catheter dialysis, with the majority in the
catheter as replacement access group (Table 2). Almost two-
thirds of patients had at least one dialysis session with
an unplanned BFR <300mL/min, the study deﬁnition of
catheter dysfunction, during their entire catheter dialysis
history. Proportions were similar between catheter as ﬁrst
and catheter as replacement access and between prior graft
and prior ﬁstula in the catheter replacement access group.
The median time to ﬁrst dialysis session with unplanned
BFR <300mL/min was longer, but not signiﬁcantly longer
(P = 0.08 by Log Rank) in the catheter as ﬁrst access group
(Figure 2). Also the rate per patient month at risk (Figure 3)
and the percent of patients with at least one session per
month with unplanned BFR <300mL/min (Figure 4)w e r e
lower in the catheter as ﬁrst access group, especially after
the ﬁrst 9 months of catheter dialysis. Patients with at
least one session meeting the study deﬁnition of catheter
dysfunction had, on average, nine sessions with unplanned
BFR <300mL/min. (Table 2; Figure 5).
Catheter as ﬁrst access group
Catheter as replacement access group
0
0.25
0.5
0.75
1
0 100 200 300 400 500 600 700 800 900
Duration of catheter dialysis (days)
Figure 1: Duration of catheter dialysis.
In the multivariate analysis using Cox’s proportional
hazards model for time to ﬁrst session with catheter dysfunc-
tion, male gender and black race (compared to white) were
associated with lower rates of catheter dysfunction (Table 3).
Catheter as replacement access following graft or ﬁstula
was associated with a signiﬁcantly higher rate of catheter
dysfunction than catheter as ﬁrst access. There was also
considerable variability in the rate of catheter dysfunction
across ESRD networks.
Patients in the highest quintile of catheter dysfunction
sessions per month had higher average monthly direct
medical costs, more missed sessions due to access problems,
and more access-related procedures than those in the lowest
quintile (Table 4). Hospitalization rates were similar across
the ﬁve groups.
4. Discussion
Little has been reported on the epidemiology of hemodial-
ysis catheter dysfunction, commonly deﬁned, including inInternational Journal of Nephrology 5
Table 3: Factors associated with catheter dysfunction∗.
Hazard ratio 95% conﬁdence interval P value
Age
<50 Reference
50–64 1.08 0.95 1.23 0.23
65–74 1.14 0.99 1.30 0.07
≥75 1.13 0.98 1.31 0.09
Gender
Female Reference
Male 0.85 0.78 0.92 <0.0001
Race
White Reference
Black 0.90 0.82 1.00 0.04
Other 0.98 0.83 1.17 0.84
Underlying cause of renal failure
Diabetes Reference
Hypertension 1.08 0.97 1.20 0.17
Glomerulonephritis 0.99 0.85 1.16 0.94
Other/unknown 1.01 0.88 1.15 0.95
Network
6 and 8 Reference
1 and 2 0.52 0.40 0.68 <0.0001
3 0.67 0.51 0.87 <0.01
5 0.64 0.54 0.76 <0.0001
7 0.53 0.43 0.65 <0.0001
9 1.21 0.96 1.52 0.10
10 1.23 0.95 1.57 0.11
11 0.74 0.61 0.89 <0.01
12 0.70 0.54 0.91 <0.01
13 0.95 0.75 1.19 0.63
14 0.89 0.76 1.05 0.16
15 0.78 0.64 0.96 0.02
16 0.77 0.64 0.92 <0.01
18 0.44 0.36 0.54 <.0001
Charlson Comorbidity Index
0 Reference
1-2 0.87 0.71 1.06 0.16
3-4 0.91 0.76 1.07 0.25
>4 0.93 0.79 1.10 0.40
Replacement access
Catheter as ﬁrst access Reference
Catheter as replacement access 1.13 1.01 1.27 0.04
NKF-KDOQI guidelines, as BFR <300mL/min. Without
understanding the epidemiology of catheter dysfunction
so deﬁned, it is not possible to assess the overall impact
of the NKF-KDOQI guideline on clinical and economic
outcomes. Presently, data on BFR are not collected within
the USRDS, or as part of CMS’s ESRD Clinical Performance
Measures Project. Therefore, DaVita clinical data linked
to Medicare administrative, and claims data provided a
unique opportunity to examine catheter dysfunction in this
population. We conducted an observational study in a large
cohort of patients who accounted for more than 23,000
months of catheter dialysis and 268,000 catheter dialysis
sessions. Although not intended to be a random sample
of all ESRD patients undergoing catheter dialysis in the6 International Journal of Nephrology
Table 4: Cost and resource use by number of catheter dysfunction sessions∗.
Catheter dysfunction
sessions/month (quintile) Patients (n)
Cost and Resource Use
Direct medical
cost∗∗
Missed sessions
due to access∗∗∗ Hospitalization∗∗∗ Catheter access
procedure∗∗∗
1 (0.04–0.32) 424 $5,390 1.2 19.2 21.3
2 (0.33–0.56) 426 $5,746 1.4 25.8 26.7
3 (0.57–1.13) 430 $5,634 1.9 23 29.9
4 (1.14–2.33) 433 $6,010 2.3 26.4 42.4
5( >2.33) 419 $6,226 2.8 26.6 56.4
All 2,132 $5,801 1.9 24.2 35.3
∗Catheter dysfunction was deﬁned as unplanned blood ﬂow rate during the dialysis session of <300mL/min.
∗∗Per month on catheter dialysis.
∗∗∗Per 100 patient months at risk.
Catheter as ﬁrst access group
Catheter as replacement access group
0
0.25
0.5
0.75
1
01 0 20 30 40 50 60 70 80 90
Time to first dialysis session with catheter dysfunction (days)
Figure 2: Time to ﬁrst dialysis session with catheter dysfunction.
Catheter dysfunction was deﬁned as unplanned blood ﬂow rate
during the dialysis session of <300mL/min.
United States, our cohort was geographically diverse and
demographically similar to the prevalent ESRD population
in 2004, the year our study began.
Our ﬁndings indicate that unplanned BFR <300mL/min
is common, occurring at least once in almost two-thirds of
patients who undergo catheter dialysis for more than eight
weeks, and occurring in approximately one-third of patients
every month. Further, the ﬁndings indicate that unplanned
BFR<300mL/minoccursinapproximately7%ofallcatheter
dialysis sessions. Having catheter access as a replacement for
a graft or ﬁstula is associated with a higher risk of catheter
dysfunction compared to catheter as the ﬁrst type of access
for dialysis. Also, having more catheter dysfunction sessions
per month is associated with higher direct medical costs,
interruptions or delays in dialysis services, and higher rates
of catheter access procedures.
There are several possible reasons why the rates we
observed may underestimate the true rates. First, we
excluded sessions in which planned or actual BFR values
were either <100mL/min or >500mL/min. We did so to
avoid misclassifying as catheter dysfunction sessions in
which BFR values were misreported in the data. Second,
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Figure 3: Rate of catheter dysfunction. Catheter dysfunction was
deﬁned as unplanned blood ﬂow rate during the dialysis session of
<300mL/min.
although NKF/KDOQI deﬁnes catheter dysfunction as BFR
<300mL/min, our deﬁnition was more conservative because
wealsorequiredtheplannedBFRtobe ≥300mL/min.Third,
actual BFR was obtained from a single measurement approx-
imately one hour after the beginning of the session. Fourth,
by requiring patients to have at least eight weeks of catheter
dialysis and to have survived at least 90 days following the
start of dialysis, we excluded patients who were on catheter
dialysis for shorter periods of time or who died within 90
daysofbeginningcatheterdialysis.Totheextentthatcatheter
dysfunction is more common sooner after placement, by
excluding patients with short-term catheter dialysis, we may
haveunderestimatedtheoverallrateofdysfunction.Catheter
dysfunction due to mechanical reasons, which is known
to occur sooner rather than later after placement, may be
disproportionately underrepresented. Also, if death during
the ﬁrst 90 days after catheter placement is related to serious
complications of catheter dysfunction, such as bloodstream
infection, by requiring at least 90-day survival, we may have
underestimatedtheimpactofcatheterdysfunctionontheuse
ofmedicalservices,inparticularonall-causehospitalization.International Journal of Nephrology 7
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Figure 4: Percent of patients with catheter dysfunction. Catheter
dysfunction was deﬁned as unplanned blood ﬂow rate during the
dialysis session of <300mL/min.
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dysfunction was deﬁned as unplanned blood ﬂow rate during the
dialysis session of <300mL/min.
In spite of these limitations, our ﬁndings suggest that
catheter hemodialysis BFR <300mL/min is common in
routine dialysis care and that it impacts on the provision of
dialysis services, as well as catheter-related procedures and
medical costs. It is uncertain how much of the disruption in
dialysis services and utilization of medical services was based
solely on the perceived need to maintain BFR >300mL/min
to ensure adequate dialysis and how much was based on
observed problems with dialysis adequacy.
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